Location Ann Arbor, Michigan, United States Regions Great Lakes, Midwestern US Gender Male Also Known As Dr. Gilbert S. Omenn
LinkedIn View on LinkedIn
Gilbert S. Omenn has been Professor of Internal Medicine, Human Genetics and Public Health and Director of the Center for Computational Medicine and Bioinformatics at the University of Michigan since 1997. From 1997 to 2002, Gilbert was the Chief Executive Officer of the University of Michigan Health System and Executive Vice President of the
University of Michigan for Medical Affairs.
Previously, Gilbert was a Professor of Medicine and of Environmental Health and Dean of the School of Public Health and Community Medicine at the University of Washington, as well as a senior member of the Fred Hutchinson Cancer Research Center. Gilbert has been an affiliate faculty member of the Institute for Systems Biology in Seattle since June 2009.
Gilbert served as a Member of the Board of Directors of Amgen Inc. for 27 years and of Rohm & Haas Company for 22 years.
Gilbert currently serves as a Member of the Board of Directors at Esperion Therapeutics Inc. and Oncofusion Therapeutics Inc.
Gilbert also serves as a Member of the Board of Directors at Etubics Corporation, a privately-held, early-stage bio-pharmaceutical company developing targeted immunotherapies and vaccine products, since December 2012.
Gilbert was a Member of the Board of Directors of Rohm & Haas Co., a manufacturer of specialty chemicals (now a wholly-owned subsidiary of The Dow Chemical Company) from May 1987 until March 2009, where he served on the Audit, Nominating, and Sustainability Committees, and of OccuLogix, Inc., an early-stage eye disease therapy company, from 2005 until 2008, serving on its Finance and Compensation Committees.
Gilbert has been a Member of the Scientific Advisory Board at Motorola, Inc., an electronics and equipment company, from 1998 to December 2010, Galectin Therapeutics, Inc. (formerly Pro-Pharmaceuticals Inc), an early-stage pharmaceutical company, since July 2009, Compendia Biosciences, Inc., a privately-held bioinformatics firm, since February 2007 until October 2012 when they were acquired by Life Technologies Corporation, InnoCentive Innovation, Inc., a privately-held open innovation and crowdsourcing company, since 2006 and Armune BioSciences, Inc. a privately-held early-stage in vitro diagnostic company, since February 2008, as well as a Director of the latter.
Gilbert’s civic, scientific and non-profit leadership roles include serving as a Member of the Board of Directors of the Harvard Medical Alumni Association, Hastings Center, the Center for Public Integrity, the U.S. Civilian R&D Foundation CRDF-Global, Population Services International, Center for Naval Analysis (CNA) and the Salzburg Global Seminar.
Previously, Gilbert served as a Member of the Board of Directors of United Way, the Fred Hutchinson Cancer Research Center and the American Association for the Advancement of Science.
Earlier Gilbert served as an Associate Director of the Office of Science and Technology Policy and Associate Director of the Office of Management and Budget in the Executive Office of the President of the United States from 1977 to 1981 and Chair of the Presidential/Congressional Commission on Risk Assessment and Risk Management from 1994 to 1997.
Gilbert has received several honors and awards and has published many significant papers, reviews and books.
Gilbert earned his Bachelor's degree summa cum laude from Princeton University, his Medical degree magna cum laude from Harvard Medical School and his Ph.D. in Genetics from the University of Washington.